Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New moms get high-tech help to prevent diabetes after pregnancy

NCT ID NCT06372860

Prevention Sponsor: University of Kansas Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a program called eMOMS that combines breastfeeding support with a diabetes prevention plan for pregnant women who were overweight or obese before pregnancy. The program was delivered by a health coach through a mobile app. Researchers wanted to see if it could help women lose weight after giving birth and breastfeed longer. The study involved 43 women and is now complete.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

43 people

The number who actually took part.

Started

Apr 2024

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Pregnant * In second trimester or early third trimester * BMI \>/= 25 and \< 35 * At least 18 years old or older * Able to read and understand English * Able to learn and use a video platform Exclusion Criteria: * Complications related to pregnancy that require emergency care * Thyroid disease * Multiple gestation * Substance abuse within last 3 years * Assisted reproductive technology (ART)-related pregnancy * Current smoker * Prior bariatric surgery * In weight-loss program within 3 months of conception * BMI \>/= 35 * Unable to attend intervention/ follow-up visits * Unwilling to self-monitor data collection * Unable to complete intervention * Presence of any condition that limits walking * Presence of any condition that limits following diet recommendations * Pregnancies complicated with fetuses diagnosed with lethal malformations/conditions

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Overweight or obesity are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Breast Feeding Obesity obesity disorder Overweight prediabetes syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Overweight or obesity Pregnancy

Contacts and locations

Locations

  • Via Christi Maternal Fetal Medicine Clinic

    Wichita, Kansas, 67218, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.